Four global health innovators, from a pool of over 100 applicants, have been chosen as the 2024 Gavi Innovation for Uptake, Scale and Equity in Immunisation (INFUSE) Pacesetters. The winners – Atlas AI from the USA, Causal Foundry from Spain, Figorr from Nigeria and Signalytic from Uganda – were selected from a shortlist of ten finalists by a panel of global health, technology and private sector experts after a two-day workshop funded by the Rockefeller Foundation in Nairobi, Kenya.

“Innovation plays a critical role in helping Gavi protect millions of people each year from preve Innovation ntable disease,” said Augustin Flory, Managing Director, Innovative Partnerships & Development Finance at Gavi. “As climate change impacts the trajectory of infectious diseases like malaria and increases the severity and frequency of outbreaks, it has become increasingly urgent to find new solutions to these challenges. This year’s INFUSE Pacesetters each offer the potential to transform immunisation delivery and at Gavi, we are committed to working with them to scale their activities and accelerate their impact.”